# Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)

> **NCT02149017** · PHASE1,PHASE2 · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **RADIATION:** SNUBH-NM-333(18F)

## Key facts

- **NCT ID:** NCT02149017
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2011-05
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** SNUH-NM-333 ligand effect was judged to be insufficient.
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149017, "Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02149017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*